Impaired efferocytosis in chronic obstructive pulmonary disease (COPD)
Damien Tiebe, 2025
This research explores how the cells lining our airways may help clear dead or dying cells in the lungs, especially in diseases like Chronic Obstructive Pulmonary Disease (COPD). If we better understand this natural cleaning process, it could lead to new ways to treat lung diseases that currently have limited options. Improving this process could reduce inflammation and tissue damage, helping to slow disease progression and preserve lung function.
In the future, this work could have important societal benefits beyond academic knowledge. For example, by identifying ways to improve how lung cells remove damaged cells, we might develop therapies that reduce inflammation and tissue damage in COPD patients. This could lead to better quality of life, fewer hospital visits, and lower healthcare costs. Strengthening the lungs’ natural ability to repair themselves could decrease reliance on expensive or invasive treatments, benefiting healthcare systems worldwide.
The findings could also influence public health policies by emphasizing the importance of preventing cigarette smoke exposure and promoting lung health. Additionally, pharmaceutical and biotechnology companies could use this knowledge to develop innovative drugs aimed at restoring or enhancing the lung’s cleaning processes, ultimately benefiting patients and healthcare providers. For communities and individuals affected by lung disease, such advancements could translate into increased life expectancy and better daily functioning.
Overall, this research supports a future where respiratory health can be maintained more sustainably, reducing the societal burden of lung diseases and improving the lives of millions globally.
| Promotor | Ken Bracke |
| Opleiding | Biomedische Wetenschappen |
| Domein | Tissue Engineering and Regenerative Medicine |
| Kernwoorden | Efferocytosis Bronchial epithelial cells BEAS-2B cell line Ferroptosis COPD (Chronic Obstructive Pulmonary Disease) Cigarette smoke extract (CSE) Cell viability assays Flow cytometry UAMC-3203 |